Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia - InvestingChannel

Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia

Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia. The company’s phone unlocking technology was used to install home-grown spyware on the mobile devices of journalists and activists. The allegations come from Amnesty International, which has based this news on the feedback received from Serbian activists.

Cellebrite DI is a leading provider of digital intelligence solutions in data extraction and mobile forensics. Law enforcement agencies typically use its technologies to extract data from mobile devices. It allows them to carry out investigations smoothly with quick access to data stored on mobile phones that are part of an investigation.

The company makes money from providing consulting and training services to organizations that use its technology for their investigative needs. It also develops custom solutions for such organizations. A large part of its revenue comes from a subscription to its software services.

watching, spying

According to Amnesty International, Cellebrite’s software was used to unlock phones and install spyware dubbed NoviSpy on multiple mobile phones. In some cases, journalists reported suspicious activities on their devices right after meeting government officials. One activist reported that his whole contacts list was immediately exported right after a meeting with officials of the BIA, the Serbian Intelligence Agency.

As Serbia’s use of Cellebrite’s tech comes under fire, it must be mentioned that this isn’t exactly the purpose of the company’s technology. While it’s true that law enforcement uses it to unlock phones, the purpose of that is to aid in investigations, not in spying on journalists and activists. Serbia got access to this software as part of a package funded by the Norwegian government through the United Nations to allow the country to fight organized crime. The use by government agencies has therefore come under fire and Norway isn’t happy either. The country’s deputy foreign minister, Maria Varteressian plans to take up the matter with the UN and Serbian authorities.

Cellebrite stock is up 140% in a year and has been on an uptrend since the Israel-Palestine conflict started in October last year. The company’s financial prospects are unlikely to be majorly impacted by this development as it isn’t directly responsible for the misuse of the product, nor did it directly supply it to the Serbian authorities. However, in the wake of Israel’s phone-exploding attack on Lebanon’s Hezbollah, spying software is being talked about more than before. This exposes the industry to stricter regulation, though we believe that is unlikely to cause much trouble as the company already has good relationships with governments due to the nature of its business.

Cellebrite DI doesn’t rank on our latest list of the 31 Most Popular Stocks Among Hedge Funds. As per our database, 30 hedge fund portfolios held CLBT at the end of the third quarter which was 32 in the previous quarter. While we acknowledge the potential of CLBT as a leading investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as CLBT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. This article was originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire